This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
After Hurricane Ian, as Floridians returned home to sodden furniture and moldy piles of debris, many with asthma could feel their chests tightening. To figure out what was safe, some sent their concerns directly to the U.S. Centers for Disease Control and Prevention. But on Tuesday — days before floods ravaged Nashville, potentially prompting similar queries — the people who would normally answer such asthma questions stopped working.
HRV Global Life Sciences, a virtual integrated pharmaceutical company, delivers the first shipment of anti-diabetic medications to Mendoza, Argentina. The consignment of USFDA-qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system. This was made possible through the leadership of Mendozas Governor Alfredo Cornejo and Indias Ambassador to Argentina, Dinesh Bhatia.
Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the companys phase 3 trial of the therapy. The ROSELLA trial enrolled 381 patients with platinum-resistant ovarian cancer across sites internationally. Patients were randomised 1:1 to receive either relacorilant plus nab-paclitaxel or nab-paclitaxel alone.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Threes still company in the world of pharmacy benefit managers. For 2024, nearly 80% of all equivalent prescription claims were processed by three familiar companies: the CVS Caremark business of CVS Health, the Express Scripts business of Cigna, and the Optum Rx business of UnitedHealth Group. The names havent changed, but shifting relationships and contract shakeups have altered the plot, with Express Scripts stepping into a new lead role.
In a rare move, the Food and Drug Administration told an unspecified number of drug companies that studies used to support therapeutic equivalence of some of their medicines have been rejected due to false data generated by a contract research organization. The agency identified “significant” problems with data integrity and the way studies were conducted by Raptim Research, which had been hired by the drugmakers to test their medicines.
In a rare move, the Food and Drug Administration told an unspecified number of drug companies that studies used to support therapeutic equivalence of some of their medicines have been rejected due to false data generated by a contract research organization. The agency identified “significant” problems with data integrity and the way studies were conducted by Raptim Research, which had been hired by the drugmakers to test their medicines.
Community Pharmacy England has agreed a 3.073 billion Community Pharmacy Contractual Framework, in a new deal for the sector for 2025/26. A further 215 million will be available for contractors to earn through Pharmacy First, blood pressure and contraception services, while a national emergency hormonal contraception service has been commissioned. The medicines margin for 2025/26 […] The post BREAKING: Community pharmacies get 3bn deal for 2025/26 appeared first on The Pharmacist.
Rx Propellant, a life sciences infrastructure platform backed by Actis, has launched 1GV, a 136,000 sq. ft. research and innovation campus in Genome Valley, Hyderabad. The facility spans 1.8 acres and is designed to support the growth of Indias life sciences sector. 1GV is built on the site where the first construction in Genome Valley took place, marking the origins of one of Asias largest life sciences clusters.
New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Dana, a 29-year-old nurse in St. Louis, checks her phone to see if the gig nursing app CareRev still has her scheduled at the local hospital. She’s already arranged child care for her son, but cancellations are common. “It’s a gamble. … I’ll wake up at 5 in the morning, and I’ll find out if I’m canceled or not,” she told us.
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability.
By Dr. Naomi Lowy, Principal Drug Regulatory Expert Trade and national press have reported that recent changes in FDA staffing levels have already led to slower responses to calls and emails. According to reports, which were published before the most recent reports of HHS staff level reductions and tumultuous changes in leadership, FDA staff were missing minor deadlines.
AGI Greenpac, has announced plans to establish a new manufacturing plant in Madhya Pradesh with an investment of approximately 700 crore. The greenfield facility is expected to increase the companys container glass production capacity by 25 per cent to address the rising demand for glass packaging across industries. The plant will have a planned daily production capacity of 500 tonnes, manufacturing commercial glass for the alcoholic beverages, pharmaceutical, and food sectors.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.
Heart disease has long been the leading killer of adults, but beyond that stark fact, men and women diverge. From differences at the cellular level of the heart to circulatory structure to symptoms of distress and treatment, researchers are finding new manifestations of gender differences in cardiovascular disease.
If you think your patients arent looking at online pharmacies for cheaper medications, youre kidding yourself. Medicine is expensiveeverything is expensive. And when people are desperate, they look for alternatives. The problem? 96% of online pharmacies are illegal. Theyre selling unregulated, potentially dangerous medications, and most patients have no idea.
A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that demonstrated a significant improvement in live birth rates. Prometrium, a 400mg soft vaginal capsule developed by Besins Healthcare, is now available in England, Wales, Scotland and Northern Ireland. It is designed for use by women […] The post New hormonal treatment launched to help prevent miscarriage in early pregnancy appeared first on Pharmafile.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
A USC-licensed startup, NeOnc Technologies, that developed an intranasal drug delivery system for brain tumors has got listed for the first time on Nasdaq. NeOnc has also announced a strategic partnership with CBCC Global Research, a CRO, to expand clinical trials across 30 FDA-compliant sites in India, facilitating the advancement of its neuro-oncology treatment.
The CDC cuts announced Tuesday threaten America’s health, safety, and economy. Despite claims of efficiency, these cuts target proven programs that prevent disease and save lives — and as a result, Americans will be sicker and face increased health care costs. The government’s goal should not be to hit an arbitrary number of jobs eliminated, but to focus on the number of illnesses and premature deaths prevented.
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Rather than relying solely on paid ads or direct promotion, referral marketing uses personal recommendations to generate awareness, interest, and ultimately, conversions.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in adults, whose disease is inadequately controlled by existing therapy. The approval in Japan was based on data from the BOREAS phase 3 study conducted by Sanofi and Regeneron. […] The post Dupixent approved as the first biologic medicine in Japan for COPD patients appeared first on Pharmafile.
Algorithmic Biologics announced the appointment of Hiranjith GH as Chief Business Officer (CBO) to lead the companys commercial operations and its expansion globally, primarily in the US. With decades of experience in the pharmaceutical and life sciences industries, Hiran brings valuable expertise in go-to-market strategy for the US, business development, solution development, and cross-border team leadership.
Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.
The forced resignation of Peter Marks , the Food and Drug Administration official in charge of regulating vaccines, gene therapies, and the blood supply, led to panic over the weekend in the worlds of public health and biopharmaceuticals — two worlds that often agree on very little aside from their belief in the safety and effectiveness of vaccines.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The new community pharmacy funding deal falls short of the costs outlined in the economic review of community pharmacy, but is 'a significant step in the right direction', Community Pharmacy England has said. Pharmacy minister Stephen Kinnock told press that he recognised the pressures that pharmacy contractors were under and said the government was 'committed […] The post CPCF: Is the new community pharmacy funding deal enough?
Analytical testing is an essential part of guaranteeing the quality, safety and effectiveness of pharmaceutical products. However, the process is not without its challenges and it requires a proactive approach if both compliance and efficiency are to be maintained. This is why it is essential to develop and validate analytical methods to support activities and functions such as process validation controls, stability tests and dissolution profiles.
Tillomed Laboratories Limited, a UK-based subsidiary of Emcure Pharmaceuticals (BSE: 544210, NSE: EMCURE), has signed an Asset Purchase Agreement (APA) with Manx Healthcare Limited and its subsidiaries Manx Pharma and Manx Generics. The acquisition will include Manxs complete product portfolio along with dossiers, marketing authorisations, intellectual property, and stock.
66
66
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
362 
Let's personalize your content